Atlas Arteria Holds 40c Distribution Despite New French Tax Extension

Extension of French Temporary Supplemental Tax

Atlas Arteria (ASX, ALX) has provided an important update regarding the French temporary supplemental tax (TST), which was initially introduced as a one-year measure in 2025. The French Parliament’s recent adoption of the 2026 Finance Law extends this tax into the new year, a development that was not anticipated when the tax was first announced.

The TST is calculated based on the company’s revenue for both 2025 and 2026, with a tiered rate structure depending on revenue thresholds. Companies with revenues between €1.5 billion and €3 billion face a 20.6% levy on the average corporate income tax due for the two years, while those exceeding €3 billion face a 41.2% rate. Atlas Arteria’s exposure to this tax reflects its significant motorway interests in France.

Financial Implications and Payment Schedule

The tax payment schedule requires 98% of the anticipated amount to be paid by December 2026, with the balance due in May 2027. This staggered payment approach allows some cash flow management flexibility, though the overall financial impact will depend on final tax assessments and currency fluctuations.

Despite this extended tax obligation, Atlas Arteria has reiterated its distribution guidance for 2025 at 40 cents per share and continues to target future distributions at or above this level. The company cites growing free cash flow as a key underpinning for this confidence, suggesting that operational performance remains robust despite the evolving tax landscape.

Broader Context and Outlook

Atlas Arteria’s portfolio spans toll road assets across France, Germany, and the United States, including a 30.8% stake in a major French motorway network and controlling interests in key US toll roads. The extension of the TST specifically impacts its French operations, which are a significant contributor to the group’s earnings.

The Finance Law’s final enactment is pending review by the French Constitutional Council and presidential assent, expected in the coming weeks. Investors will be watching closely for any last-minute changes or clarifications that could affect the company’s tax liabilities or distribution capacity.

Overall, Atlas Arteria’s steady guidance amidst regulatory uncertainty reflects a disciplined approach to managing external risks while maintaining shareholder returns. The company’s ability to absorb the tax extension without altering its distribution target will be a key metric for market confidence moving forward.